












Elli Papaemmanuil
Founder at Isabl
Elli Papaemmanuil was the founder of Isabl which went through YC in W20. Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations.
Follow Elli
Previously at

University of Cambridge
Pharmaceutical Sector | Genomics Companies | Precision Medicine | Technology Architecture
MSKCC

Memorial Sloan Kettering Cancer Center

Wellcome Trust Sanger Institute

Deloitte IP Advisory
Delloitte

Deloitte

The Institute of Cancer Research

Astrazeneca
Alumnus of
University of London
University of Glasgow